CNS Drugs Journal Issues Research Articles in April 2020 Edition
April 04, 2020
April 04, 2020
CHAM, Switzerland, April 4 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its April 2020 edition:
* Achieving Smoking Cessation Among Persons with Opioid Use Disorder
* Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatm . . .
* Achieving Smoking Cessation Among Persons with Opioid Use Disorder
* Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatm . . .
